Gastrointestinal infections and the development of irritable bowel syndrome

Current Opinion in Infectious Diseases

Volumn 24, Issue 5, 2011, Pages 503-508

  Dupont, Herbert L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

bacterial diarrhea; functional gastrointestinal disorders; irritable bowel syndrome; postinfectious irritable bowel syndrome

Indexed keywords

ANXIETY; CAMPYLOBACTER; DEPRESSION; ESCHERICHIA COLI; GASTROINTESTINAL INFECTION; HEMATOCHEZIA; HUMAN; INFECTION COMPLICATION; INTESTINE MOTILITY; IRRITABLE COLON; NONHUMAN; REVIEW; SALMONELLA; STRESS; VISCERAL PAIN;

GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; RISK FACTORS;

EID: 80052429007     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32834a962d     Document Type: Review

References (49)

1. Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol 2010; 105:814-820; quiz 3, 21.
2. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome-a tale of one or two disorders? Aliment Pharmacol Ther 2004; 20 (Suppl 7):40-49. (Pubitemid 39657675)
3. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003; 98:1578-1583. (Pubitemid 36875351)
4. Thornley JP, Jenkins D, Neal K, et al. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001; 184:606-609. (Pubitemid 32783552)
5. Okhuysen PC, Jiang ZD, Carlin L, et al. Postdiarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004; 99:1774-1778. (Pubitemid 39237507)
6. DuPont HL, Galler G, Garcia-Torres F, et al. Travel and travelers' diarrhea in patients with irritable bowel syndrome. Am J Trop Med Hyg 2010; 82:301-305.
7. Stermer E, Lubezky A, Potasman I, et al. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006; 43:898-901. (Pubitemid 44435519)
8. Tuteja AK, Talley NJ, Gelman SS, et al. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008; 53:271-276. (Pubitemid 350265680)
9. Porter CK, Gormley R, Tribble DR, et al. The incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population. Am J Gastroenterol 2011; 106:130-138.
10. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 2009; 80:609-614.
11. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26:535-544. (Pubitemid 47174284)
12. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131:445-450; quiz 660. (Pubitemid 44142459)
13. Ji S, Park H, Lee D, et al. Postinfectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20:381-386. (Pubitemid 40469337)
14. Haagsma JA, Siersema PD, De Wit NJ, Havelaar AH. Disease burden of postinfectious irritable bowel syndrome in The Netherlands. Epidemiol Infect 2010; 138:1650-1656.
15. Dizdar V, Spiller R, Singh G, et al. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31:883-891.
16. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 2009; 9:27.
17. Marshall JK, Thabane M, Borgaonkar MR, James C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastroenterol Hepatol 2007; 5:457-460. (Pubitemid 46575359)
18. Saps M, Pensabene L, Di Martino L, et al. Postinfectious functional gastrointestinal disorders in children. J Pediatr 2008; 152:812-816, 6 e1.
19. Thabane M, Simunovic M, Akhtar-Danesh N, et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol 2010; 105:933-939.
20. Parry SD, Corbett S, James P, et al. Illness perceptions in people with acute bacterial gastro-enteritis. J Health Psychol 2003; 8:693-704. (Pubitemid 37377099)
21. Thabane M, Simunovic M, Akhtar-Danesh N, Marshall JK. Development and validation of a risk score for postinfectious irritable bowel syndrome. Am J Gastroenterol 2009; 104:2267-2274.
22. Parry SD, Barton JR, Welfare MR. Factors associated with the development of postinfectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol 2005; 17:1071-1075. (Pubitemid 41424000)
23. Gwee KA. Post-infectious irritable bowel syndrome, an inflammationimmunological model with relevance for other IBS and functional dyspepsia. J Neurogastroenterol Motil 2010; 16:30-34.
24. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125:1651-1659. (Pubitemid 37500429)
25. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired postinfectious irritable bowel syndrome. Gut 2003; 52:523-526. (Pubitemid 36363405)
26. Bhuiyan MR, Majumder TK, Raihan AA, et al. Histopathological alterations in postinfectious irritable bowel syndrome in Bangladeshi population. Mymensingh Med J 2010; 19:275-281.
27. Kindt S, Tertychnyy A, de Hertogh G, et al. Intestinal immune activation in presumed postinfectious functional dyspepsia. Neurogastroenterol Motil 2009; 21:832-856.
28. Leng YX, Wei YY, Chen H, et al. Alteration of cholinergic and peptidergic neurotransmitters in rat ileum induced by acute stress following transient intestinal infection is mast cell dependent. Chin Med J (Engl) 2010; 123: 227-233.
29. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 2007; 19 (Suppl 2):25-31. (Pubitemid 47037963)
30. Kiank C, Tache Y, Larauche M. Stress-related modulation of inflammation in experimental models of bowel disease and postinfectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav Immun 2010; 24:41-48.
31. Lee KJ, Kim YB, Kim JH, et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008; 23:1689-1694.
32. Elsenbruch S. Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2010; 25:386-394.
33. Elsenbruch S, Rosenberger C, Enck P, et al. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 2010; 59:489-495.
34. Barbara G, De Giorgio R, Stanghellini V, et al. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004; (Suppl 2):1-9. (Pubitemid 39237523)
35. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004; 292:852-858. (Pubitemid 39079672)
36. Pimentel M, Lembo A,CheyWD,et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364:22-32.
37. Marshall JK, Thabane M, Garg AX, et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 2004; 20:1317-1322. (Pubitemid 40040078)
38. Moss-Morris R, Spence M. To 'lump' or to 'split' the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med 2006; 68:463-469. (Pubitemid 44297680)
39. Villani AC, Lemire M, Thabane M, et al. Genetic risk factors for postinfectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138:1502-1513.
40. van der Veek PP, van den Berg M, de Kroon YE, et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005; 100:2510-2516.
41. Qin HY, Wu JC, Tong XD, et al. Systematic review of animal models of postinfectious/post-inflammatory irritable bowel syndrome. J Gastroenterol 2010; 46:164-174.
42. Keating C, Beyak M, Foley S, et al. Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism. J Physiol 2008; 586:4517-4530.
43. Pimentel M, Chatterjee S, Chang C, et al. A new rat model links two contemporary theories in irritablebowel syndrome. Dig DisSci 2008; 53:982-989. (Pubitemid 351379840)
44. Pimentel M, Morales W, Jee SR, et al. Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of postinfectious IBS. Dig Dis Sci 2011; 56:1962-1966.
45. Neal KR, Barker L, Spiller RC. Prognosis in postinfective irritable bowel syndrome: a six year follow up study. Gut 2002; 51:410-413.
46. Kim HS, Kim MS, Ji SW, Park H. The development of irritable bowel syndrome after Shigella infection: 3 year follow-up study. Korean J Gastroenterol 2006; 47:300-305.
47. Tornblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007; 5:461-464. (Pubitemid 46575368)
48. Jung IS, Kim HS, Park H, Lee SI. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. J Clin Gastroenterol 2009; 43:534-540.
49. Marshall JK, Thabane M, Garg AX, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010; 59:605-611.